{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:44:29Z","timestamp":1790516669480,"version":"4.1.0"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human T-lymphotropic virus type 1 (HTLV-1) is associated with adult T cell leukemia\/lymphoma and HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). HAM\/TSP is an inflammatory disease of the spinal cord and clinically characterized by progressive spastic paraparesis, urinary incontinence, and mild sensory disturbance. The interaction between the host immune response and HTLV-1-infected cells regulates the development of HAM\/TSP. HTLV-1 preferentially infects CD4<jats:sup>+<\/jats:sup>T cells and is maintained by proliferation of the infected T cells. HTLV-1-infected cells rarely express viral antigens in vivo; however, they easily express the antigens after short-term culture. Therefore, such virus-expressing cells may lead to activation and expansion of antigen-specific T cell responses. Infected T cells with HTLV-1 and HTLV-1-specific CD8<jats:sup>+<\/jats:sup>cytotoxic T lymphocytes invade the central nervous system and produce various proinflammatory cytokines and chemokines, leading to neuronal damage and degeneration. Therefore, cellular immune responses to HTLV-1 have been considered to play important roles in disease development of HAM\/TSP. Recent studies have clarified the viral strategy for persistence in the host through genetic and epigenetic changes by HTLV-1 and host immune responses including T cell function and differentiation. Newly developed animal models could provide the opportunity to uncover the precise pathogenesis and development of clinically effective treatment. Several molecular target drugs are undergoing clinical trials with promising efficacy. In this review, we summarize recent advances in the immunopathogenesis of HAM\/TSP and discuss the perspectives of the research on this disease.<\/jats:p>","DOI":"10.1007\/s13365-020-00881-w","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T14:03:41Z","timestamp":1595513021000},"page":"652-663","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy\/tropical spastic paraparesis"],"prefix":"10.1007","volume":"26","author":[{"given":"Satoshi","family":"Nozuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,23]]},"reference":[{"issue":"7","key":"881_CR1","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/infdis\/jiq153","volume":"203","author":"NH Abdelbary","year":"2011","unstructured":"Abdelbary NH, Abdullah HM, Matsuzaki T, Hayashi D, Tanaka Y, Takashima H, Izumo S, Kubota R (2011) Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection. J Infect Dis 203(7):948\u2013959. https:\/\/doi.org\/10.1093\/infdis\/jiq153","journal-title":"J Infect Dis"},{"key":"881_CR2","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.3389\/fmicb.2016.01674","volume":"7","author":"C Alvarez","year":"2016","unstructured":"Alvarez C, Gotuzzo E, Vandamme AM, Verdonck K (2016) Family aggregation of human T-Lymphotropic virus 1-associated diseases: a systematic review. Front Microbiol 7:1674. https:\/\/doi.org\/10.3389\/fmicb.2016.01674","journal-title":"Front Microbiol"},{"issue":"1","key":"881_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/s41598-018-36274-7","volume":"9","author":"AP Alves Sousa","year":"2019","unstructured":"Alves Sousa AP, Johnson KR, Ohayon J, Zhu J, Muraro PA, Jacobson S (2019) Comprehensive analysis of TCR-beta repertoire in patients with neurological immune-mediated disorders. Sci Rep 9(1):344. https:\/\/doi.org\/10.1038\/s41598-018-36274-7","journal-title":"Sci Rep"},{"issue":"1","key":"881_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40169-018-0204-7","volume":"7","author":"MR Anderson","year":"2018","unstructured":"Anderson MR, Pleet ML, Enose-Akahata Y, Erickson J, Monaco MC, Akpamagbo Y, Velluci A, Tanaka Y, Azodi S, Lepene B, Jones J, Kashanchi F, Jacobson S (2018) Viral antigens detectable in CSF exosomes from patients with retrovirus associated neurologic disease: functional role of exosomes. Clin Transl Med 7(1):24. https:\/\/doi.org\/10.1186\/s40169-018-0204-7","journal-title":"Clin Transl Med"},{"issue":"Pt 9","key":"881_CR5","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1093\/brain\/awt183","volume":"136","author":"H Ando","year":"2013","unstructured":"Ando H, Sato T, Tomaru U, Yoshida M, Utsunomiya A, Yamauchi J, Araya N, Yagishita N, Coler-Reilly A, Shimizu Y, Yudoh K, Hasegawa Y, Nishioka K, Nakajima T, Jacobson S, Yamano Y (2013) Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. Brain 136(Pt 9):2876\u20132887. https:\/\/doi.org\/10.1093\/brain\/awt183","journal-title":"Brain"},{"issue":"8","key":"881_CR6","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1172\/JCI75250","volume":"124","author":"N Araya","year":"2014","unstructured":"Araya N, Sato T, Ando H, Tomaru U, Yoshida M, Coler-Reilly A, Yagishita N, Yamauchi J, Hasegawa A, Kannagi M, Hasegawa Y, Takahashi K, Kunitomo Y, Tanaka Y, Nakajima T, Nishioka K, Utsunomiya A, Jacobson S, Yamano Y (2014) HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells. J Clin Invest 124(8):3431\u20133442. https:\/\/doi.org\/10.1172\/JCI75250","journal-title":"J Clin Invest"},{"issue":"4","key":"881_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/13550280701397627","volume":"13","author":"K Arimura","year":"2007","unstructured":"Arimura K, Nakagawa M, Izumo S, Usuku K, Itoyama Y, Kira J, Osame M (2007) Safety and efficacy of interferon-alpha in 167 patients with human T-cell lymphotropic virus type 1-associated myelopathy. J Neuro-Oncol 13(4):364\u2013372. https:\/\/doi.org\/10.1080\/13550280701397627","journal-title":"J Neuro-Oncol"},{"issue":"9","key":"881_CR8","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","volume":"112","author":"J Arnold","year":"2008","unstructured":"Arnold J, Zimmerman B, Li M, Lairmore MD, Green PL (2008) Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 112(9):3788\u20133797. https:\/\/doi.org\/10.1182\/blood-2008-04-154286","journal-title":"Blood"},{"issue":"Pt 5","key":"881_CR9","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1099\/vir.0.80766-0","volume":"86","author":"B Asquith","year":"2005","unstructured":"Asquith B, Mosley AJ, Barfield A, Marshall SE, Heaps A, Goon P et al (2005) A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol 86(Pt 5):1515\u20131523. https:\/\/doi.org\/10.1099\/vir.0.80766-0","journal-title":"J Gen Virol"},{"issue":"5","key":"881_CR10","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.immuni.2016.04.022","volume":"44","author":"J Attanasio","year":"2016","unstructured":"Attanasio J, Wherry EJ (2016) Costimulatory and coinhibitory receptor pathways in infectious disease. Immunity 44(5):1052\u20131068. https:\/\/doi.org\/10.1016\/j.immuni.2016.04.022","journal-title":"Immunity"},{"issue":"3","key":"881_CR11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s004019900170","volume":"100","author":"MM Aye","year":"2000","unstructured":"Aye MM, Matsuoka E, Moritoyo T, Umehara F, Suehara M, Hokezu Y, Yamanaka H, Isashiki Y, Osame M, Izumo S (2000) Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy\/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol 100(3):245\u2013252","journal-title":"Acta Neuropathol"},{"issue":"7","key":"881_CR12","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.4049\/jimmunol.163.7.4064","volume":"163","author":"N Azimi","year":"1999","unstructured":"Azimi N, Jacobson S, Leist T, Waldmann TA (1999) Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2\/15R beta receptor. J Immunol 163(7):4064\u20134072","journal-title":"J Immunol"},{"issue":"7","key":"881_CR13","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/eji.200939451","volume":"39","author":"CR Bangham","year":"2009","unstructured":"Bangham CR (2009) CTL quality and the control of human retroviral infections. Eur J Immunol 39(7):1700\u20131712. https:\/\/doi.org\/10.1002\/eji.200939451","journal-title":"Eur J Immunol"},{"key":"881_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/B978-0-12-385524-4.00004-0","volume":"111","author":"CR Bangham","year":"2011","unstructured":"Bangham CR, Toulza F (2011) Adult T cell leukemia\/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1. Adv Cancer Res 111:163\u2013182. https:\/\/doi.org\/10.1016\/B978-0-12-385524-4.00004-0","journal-title":"Adv Cancer Res"},{"key":"881_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","volume":"36","author":"CRM Bangham","year":"2018","unstructured":"Bangham CRM (2018) Human T cell leukemia virus type 1: persistence and pathogenesis. Annu Rev Immunol 36:43\u201371. https:\/\/doi.org\/10.1146\/annurev-immunol-042617-053222","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"881_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005285","volume":"11","author":"M Baratella","year":"2017","unstructured":"Baratella M, Forlani G, Raval GU, Tedeschi A, Gout O, Gessain A, Tosi G, Accolla RS (2017) Cytoplasmic localization of HTLV-1 HBZ protein: a biomarker of HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). PLoS Negl Trop Dis 11(1):e0005285. https:\/\/doi.org\/10.1371\/journal.pntd.0005285","journal-title":"PLoS Negl Trop Dis"},{"key":"881_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12688\/wellcomeopenres.12469.2","volume":"2","author":"MR Billman","year":"2017","unstructured":"Billman MR, Rueda D, Bangham CRM (2017) Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1. Wellcome Open Res 2:87. https:\/\/doi.org\/10.12688\/wellcomeopenres.12469.2","journal-title":"Wellcome Open Res"},{"issue":"20","key":"881_CR18","doi-asserted-by":"publisher","first-page":"9836","DOI":"10.1128\/JVI.75.20.9836-9843.2001","volume":"75","author":"KD Bourcier","year":"2001","unstructured":"Bourcier KD, Lim DG, Ding YH, Smith KJ, Wucherpfennig K, Hafler DA (2001) Conserved CDR3 regions in T-cell receptor (TCR) CD8(+) T cells that recognize the Tax11-19\/HLA-A*0201 complex in a subject infected with human T-cell leukemia virus type 1: relationship of T-cell fine specificity and major histocompatibility complex\/peptide\/TCR crystal structure. J Virol 75(20):9836\u20139843. https:\/\/doi.org\/10.1128\/JVI.75.20.9836-9843.2001","journal-title":"J Virol"},{"issue":"5","key":"881_CR19","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.immuni.2016.04.023","volume":"44","author":"MK Callahan","year":"2016","unstructured":"Callahan MK, Postow MA, Wolchok JD (2016) Targeting T cell co-receptors for cancer therapy. Immunity 44(5):1069\u20131078. https:\/\/doi.org\/10.1016\/j.immuni.2016.04.023","journal-title":"Immunity"},{"issue":"1","key":"881_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13023-016-0451-x","volume":"11","author":"AL Coler-Reilly","year":"2016","unstructured":"Coler-Reilly AL, Yagishita N, Suzuki H, Sato T, Araya N, Inoue E et al (2016) Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net). Orphanet J Rare Dis 11(1):69. https:\/\/doi.org\/10.1186\/s13023-016-0451-x","journal-title":"Orphanet J Rare Dis"},{"issue":"17","key":"881_CR21","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1182\/blood-2012-07-445593","volume":"120","author":"LB Cook","year":"2012","unstructured":"Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CR (2012) HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood 120(17):3488\u20133490. https:\/\/doi.org\/10.1182\/blood-2012-07-445593","journal-title":"Blood"},{"issue":"1\u20132","key":"881_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jns.2008.01.004","volume":"269","author":"MG Croda","year":"2008","unstructured":"Croda MG, de Oliveira AC, Vergara MP, Bonasser F, Smid J, Duarte AJ et al (2008) Corticosteroid therapy in TSP\/HAM patients: the results from a 10 years open cohort. J Neurol Sci 269(1\u20132):133\u2013137. https:\/\/doi.org\/10.1016\/j.jns.2008.01.004","journal-title":"J Neurol Sci"},{"issue":"7","key":"881_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5694\/mja16.00285","volume":"205","author":"LJ Einsiedel","year":"2016","unstructured":"Einsiedel LJ, Pham H, Woodman RJ, Pepperill C, Taylor KA (2016) The prevalence and clinical associations of HTLV-1 infection in a remote indigenous community. Med J Aust 205(7):305\u2013309","journal-title":"Med J Aust"},{"issue":"12","key":"881_CR24","doi-asserted-by":"crossref","first-page":"6674","DOI":"10.4049\/jimmunol.161.12.6674","volume":"161","author":"N Eiraku","year":"1998","unstructured":"Eiraku N, Hingorani R, Ijichi S, Machigashira K, Gregersen PK, Monteiro J et al (1998) Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. J Immunol 161(12):6674\u20136680","journal-title":"J Immunol"},{"key":"881_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-10-19","volume":"10","author":"Y Enose-Akahata","year":"2013","unstructured":"Enose-Akahata Y, Abrams A, Massoud R, Bialuk I, Johnson KR, Green PL, Maloney EM, Jacobson S (2013) Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals. Retrovirology 10:19. https:\/\/doi.org\/10.1186\/1742-4690-10-19","journal-title":"Retrovirology"},{"issue":"12","key":"881_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000682","volume":"5","author":"Y Enose-Akahata","year":"2009","unstructured":"Enose-Akahata Y, Matsuura E, Oh U, Jacobson S (2009) High expression of CD244 and SAP regulated CD8 T cell responses of patients with HTLV-I associated neurologic disease. PLoS Pathog 5(12):e1000682. https:\/\/doi.org\/10.1371\/journal.ppat.1000682","journal-title":"PLoS Pathog"},{"issue":"6","key":"881_CR27","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1182\/blood-2008-02-138529","volume":"112","author":"Y Enose-Akahata","year":"2008","unstructured":"Enose-Akahata Y, Oh U, Grant C, Jacobson S (2008) Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease. Blood 112(6):2400\u20132410. https:\/\/doi.org\/10.1182\/blood-2008-02-138529","journal-title":"Blood"},{"issue":"8","key":"881_CR28","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/acn3.50820","volume":"6","author":"Y Enose-Akahata","year":"2019","unstructured":"Enose-Akahata Y, Oh U, Ohayon J, Billioux BJ, Massoud R, Bryant BR, Vellucci A, Ngouth N, Cortese I, Waldmann TA, Jacobson S (2019) Clinical trial of a humanized anti-IL-2\/IL-15 receptor beta chain in HAM\/TSP. Ann Clin Transl Neurol 6(8):1383\u20131394. https:\/\/doi.org\/10.1002\/acn3.50820","journal-title":"Ann Clin Transl Neurol"},{"key":"881_CR29","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.3389\/fmicb.2017.02563","volume":"8","author":"Y Enose-Akahata","year":"2017","unstructured":"Enose-Akahata Y, Vellucci A, Jacobson S (2017) Role of HTLV-1 Tax and HBZ in the pathogenesis of HAM\/TSP. Front Microbiol 8:2563. https:\/\/doi.org\/10.3389\/fmicb.2017.02563","journal-title":"Front Microbiol"},{"key":"881_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41525-019-0084-9","volume":"4","author":"A Farmanbar","year":"2019","unstructured":"Farmanbar A, Kneller R, Firouzi S (2019) RNA sequencing identifies clonal structure of T-cell repertoires in patients with adult T-cell leukemia\/lymphoma. NPJ Genom Med 4:10. https:\/\/doi.org\/10.1038\/s41525-019-0084-9","journal-title":"NPJ Genom Med"},{"key":"881_CR31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3389\/fmicb.2019.00819","volume":"10","author":"G Forlani","year":"2019","unstructured":"Forlani G, Baratella M, Tedeschi A, Pique C, Jacobson S, Accolla RS (2019) HTLV-1 HBZ protein resides exclusively in the cytoplasm of infected cells in asymptomatic carriers and HAM\/TSP patients. Front Microbiol 10:819. https:\/\/doi.org\/10.3389\/fmicb.2019.00819","journal-title":"Front Microbiol"},{"issue":"5","key":"881_CR32","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1086\/315897","volume":"182","author":"Y Furukawa","year":"2000","unstructured":"Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M (2000) Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the Tax gene and their association with different risks for HTLV-I-associated myelopathy\/tropical spastic paraparesis. J Infect Dis 182(5):1343\u20131349. https:\/\/doi.org\/10.1086\/315897","journal-title":"J Infect Dis"},{"issue":"11","key":"881_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006722","volume":"13","author":"R Furuta","year":"2017","unstructured":"Furuta R, Yasunaga JI, Miura M, Sugata K, Saito A, Akari H, Ueno T, Takenouchi N, Fujisawa JI, Koh KR, Higuchi Y, Mahgoub M, Shimizu M, Matsuda F, Melamed A, Bangham CR, Matsuoka M (2017) Human T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo. PLoS Pathog 13(11):e1006722. https:\/\/doi.org\/10.1371\/journal.ppat.1006722","journal-title":"PLoS Pathog"},{"issue":"24","key":"881_CR34","doi-asserted-by":"publisher","first-page":"12813","DOI":"10.1128\/JVI.76.24.12813-12822.2002","volume":"76","author":"G Gaudray","year":"2002","unstructured":"Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C, Mesnard JM (2002) The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 76(24):12813\u201312822","journal-title":"J Virol"},{"issue":"8452","key":"881_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"2","author":"A Gessain","year":"1985","unstructured":"Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de Th\u00e9 G (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2(8452):407\u2013410","journal-title":"Lancet"},{"key":"881_CR36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O (2012) Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 3:388. https:\/\/doi.org\/10.3389\/fmicb.2012.00388","journal-title":"Front Microbiol"},{"issue":"3","key":"881_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neurol.2011.12.006","volume":"168","author":"A Gessain","year":"2012","unstructured":"Gessain A, Mahieux R (2012) Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects. Rev Neurol (Paris) 168(3):257\u2013269. https:\/\/doi.org\/10.1016\/j.neurol.2011.12.006","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"881_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s11481-017-9740-y","volume":"12","author":"R Ginwala","year":"2017","unstructured":"Ginwala R, Caruso B, Khan ZK, Pattekar A, Chew GM, Corley MJ, Loonawat R, Jacobson S, Sreedhar S, Ndhlovu LC, Jain P (2017) HTLV-1 infection and Neuropathogenesis in the context of Rag1(-\/-)gammac(-\/-) (RAG1-Hu) and BLT mice. J NeuroImmune Pharmacol 12(3):504\u2013520. https:\/\/doi.org\/10.1007\/s11481-017-9740-y","journal-title":"J NeuroImmune Pharmacol"},{"issue":"13","key":"881_CR39","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.1073\/pnas.95.13.7568","volume":"95","author":"TF Greten","year":"1998","unstructured":"Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S, Schneck JP (1998) Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19-specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM\/TSP patients. Proc Natl Acad Sci U S A 95(13):7568\u20137573","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"881_CR40","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1089\/08892220050193191","volume":"16","author":"E Hanon","year":"2000","unstructured":"Hanon E, Asquith RE, Taylor GP, Tanaka Y, Weber JN, Bangham CR (2000a) High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells. AIDS Res Hum Retrovir 16(16):1711\u20131715. https:\/\/doi.org\/10.1089\/08892220050193191","journal-title":"AIDS Res Hum Retrovir"},{"issue":"4","key":"881_CR41","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","volume":"95","author":"E Hanon","year":"2000","unstructured":"Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN, Bangham CRM (2000b) Abundant Tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95(4):1386\u20131392","journal-title":"Blood"},{"issue":"1","key":"881_CR42","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1158\/0008-5472.can-03-1452","volume":"64","author":"N Harashima","year":"2004","unstructured":"Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M, Ohashi T, Fukui F, Hasegawa A, Masuda T, Takaue Y, Okamura J, Kannagi M (2004) Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 64(1):391\u2013399. https:\/\/doi.org\/10.1158\/0008-5472.can-03-1452","journal-title":"Cancer Res"},{"issue":"4","key":"881_CR43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nm1389","volume":"12","author":"H Hasegawa","year":"2006","unstructured":"Hasegawa H, Sawa H, Lewis MJ, Orba Y, Sheehy N, Yamamoto Y, Ichinohe T, Tsunetsugu-Yokota Y, Katano H, Takahashi H, Matsuda J, Sata T, Kurata T, Nagashima K, Hall WW (2006) Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 12(4):466\u2013472. https:\/\/doi.org\/10.1038\/nm1389","journal-title":"Nat Med"},{"issue":"2","key":"881_CR44","doi-asserted-by":"publisher","first-page":"931","DOI":"10.4049\/jimmunol.180.2.931","volume":"180","author":"K Hieshima","year":"2008","unstructured":"Hieshima K, Nagakubo D, Nakayama T, Shirakawa AK, Jin Z, Yoshie O (2008) Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells. J Immunol 180(2):931\u2013939","journal-title":"J Immunol"},{"issue":"4","key":"881_CR45","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/infdis\/jiq078","volume":"203","author":"S Hilburn","year":"2011","unstructured":"Hilburn S, Rowan A, Demontis MA, MacNamara A, Asquith B, Bangham CR, Taylor GP (2011) In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. J Infect Dis 203(4):529\u2013536. https:\/\/doi.org\/10.1093\/infdis\/jiq078","journal-title":"J Infect Dis"},{"issue":"Pt 7","key":"881_CR46","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1242\/jcs.01727","volume":"118","author":"P Hivin","year":"2005","unstructured":"Hivin P, Frederic M, Arpin-Andre C, Basbous J, Gay B, Thebault S et al (2005) Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs. J Cell Sci 118(Pt 7):1355\u20131362. https:\/\/doi.org\/10.1242\/jcs.01727","journal-title":"J Cell Sci"},{"key":"881_CR47","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3389\/fmicb.2012.00222","volume":"3","author":"H Hoshino","year":"2012","unstructured":"Hoshino H (2012) Cellular factors involved in HTLV-1 entry and pathogenicit. Front Microbiol 3:222. https:\/\/doi.org\/10.3389\/fmicb.2012.00222","journal-title":"Front Microbiol"},{"issue":"4","key":"881_CR48","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.176.4.981","volume":"176","author":"N Ishiguro","year":"1992","unstructured":"Ishiguro N, Abe M, Seto K, Sakurai H, Ikeda H, Wakisaka A, Togashi T, Tateno M, Yoshiki T (1992) A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy\/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J Exp Med 176(4):981\u2013989. https:\/\/doi.org\/10.1084\/jem.176.4.981","journal-title":"J Exp Med"},{"issue":"6","key":"881_CR49","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/ejh.12940","volume":"99","author":"C Ishikawa","year":"2017","unstructured":"Ishikawa C, Senba M, Hashimoto T, Imaizumi A, Mori N (2017) Expression and significance of Pim-3 kinase in adult T-cell leukemia. Eur J Haematol 99(6):495\u2013504. https:\/\/doi.org\/10.1111\/ejh.12940","journal-title":"Eur J Haematol"},{"issue":"7","key":"881_CR50","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1056\/NEJMc1807852","volume":"379","author":"K Ishitsuka","year":"2018","unstructured":"Ishitsuka K, Utsunomiya A, Ishida T (2018) PD-1 inhibitor therapy in adult T-cell leukemia-lymphoma. N Engl J Med 379(7):695\u2013697. https:\/\/doi.org\/10.1056\/NEJMc1807852","journal-title":"N Engl J Med"},{"issue":"1","key":"881_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0022-510X(90)90060-Z","volume":"96","author":"Y Iwasaki","year":"1990","unstructured":"Iwasaki Y (1990) Pathology of chronic myelopathy associated with HTLV-I infection (HAM\/TSP). J Neurol Sci 96(1):103\u2013123","journal-title":"J Neurol Sci"},{"issue":"4","key":"881_CR52","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","volume":"46","author":"S Izumo","year":"1996","unstructured":"Izumo S, Goto I, Itoyama Y, Okajima T, Watanabe S, Kuroda Y, Araki S, Mori M, Nagataki M, Matsukura S, Akamine T, Nakagawa M, Yamamoto I, Osame M (1996) Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology 46(4):1016\u20131021","journal-title":"Neurology"},{"issue":"Suppl","key":"881_CR53","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1046\/j.1440-1789.2000.00320.x","volume":"20","author":"S Izumo","year":"2000","unstructured":"Izumo S, Umehara F, Osame M (2000) HTLV-I-associated myelopathy. Neuropathology 20(Suppl):S65\u2013S68","journal-title":"Neuropathology"},{"issue":"6298","key":"881_CR54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/348245a0","volume":"348","author":"S Jacobson","year":"1990","unstructured":"Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990) Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348(6298):245\u2013248. https:\/\/doi.org\/10.1038\/348245a0","journal-title":"Nature"},{"issue":"6","key":"881_CR55","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/v3060794","volume":"3","author":"KS Jones","year":"2011","unstructured":"Jones KS, Lambert S, Bouttier M, Benit L, Ruscetti FW, Hermine O et al (2011) Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors. Viruses 3(6):794\u2013810. https:\/\/doi.org\/10.3390\/v3060794","journal-title":"Viruses"},{"issue":"2","key":"881_CR56","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s004010050962","volume":"97","author":"T Kasai","year":"1999","unstructured":"Kasai T, Ikeda H, Tomaru U, Yamashita I, Ohya O, Morita K et al (1999) A rat model of human T lymphocyte virus type I (HTLV-I) infection: in situ detection of HTLV-I provirus DNA in microglia\/macrophages in affected spinal cords of rats with HTLV-1-induced chronic progressive myeloneuropathy. Acta Neuropathologica 97(2):107\u2013112. https:\/\/doi.org\/10.1007\/s004010050962","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"881_CR57","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","volume":"131","author":"K Kataoka","year":"2018","unstructured":"Kataoka K, Iwanaga M, Yasunaga JI, Nagata Y, Kitanaka A, Kameda T, Yoshimitsu M, Shiraishi Y, Sato-Otsubo A, Sanada M, Chiba K, Tanaka H, Ochi Y, Aoki K, Suzuki H, Shiozawa Y, Yoshizato T, Sato Y, Yoshida K, Nosaka K, Hishizawa M, Itonaga H, Imaizumi Y, Munakata W, Shide K, Kubuki Y, Hidaka T, Nakamaki T, Ishiyama K, Miyawaki S, Ishii R, Nureki O, Tobinai K, Miyazaki Y, Takaori-Kondo A, Shibata T, Miyano S, Ishitsuka K, Utsunomiya A, Shimoda K, Matsuoka M, Watanabe T, Ogawa S (2018) Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma. Blood 131(2):215\u2013225. https:\/\/doi.org\/10.1182\/blood-2017-01-761874","journal-title":"Blood"},{"issue":"34","key":"881_CR58","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1038\/onc.2015.510","volume":"35","author":"A Kawatsuki","year":"2016","unstructured":"Kawatsuki A, Yasunaga JI, Mitobe Y, Green PL, Matsuoka M (2016) HTLV-1 bZIP factor protein targets the Rb\/E2F-1 pathway to promote proliferation and apoptosis of primary CD4(+) T cells. Oncogene 35(34):4509\u20134517. https:\/\/doi.org\/10.1038\/onc.2015.510","journal-title":"Oncogene"},{"issue":"1","key":"881_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006120","volume":"13","author":"H Kinosada","year":"2017","unstructured":"Kinosada H, Yasunaga JI, Shimura K, Miyazato P, Onishi C, Iyoda T, Inaba K, Matsuoka M (2017) HTLV-1 bZIP factor enhances T-cell proliferation by impeding the suppressive signaling of co-inhibitory receptors. PLoS Pathog 13(1):e1006120. https:\/\/doi.org\/10.1371\/journal.ppat.1006120","journal-title":"PLoS Pathog"},{"issue":"7","key":"881_CR60","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1128\/JVI.65.7.3770-3778.1991","volume":"65","author":"F Komurian","year":"1991","unstructured":"Komurian F, Pelloquin F, de The G (1991) In vivo genomic variability of human T-cell leukemia virus type I depends more upon geography than upon pathologies. J Virol 65(7):3770\u20133778","journal-title":"J Virol"},{"issue":"11","key":"881_CR61","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.humimm.2011.07.308","volume":"72","author":"T Kozako","year":"2011","unstructured":"Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N (2011) Programmed death-1 (PD-1)\/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy\/tropical spastic paraparesis and carriers with autoimmune disorders. Hum Immunol 72(11):1001\u20131006. https:\/\/doi.org\/10.1016\/j.humimm.2011.07.308","journal-title":"Hum Immunol"},{"issue":"2","key":"881_CR62","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/leu.2008.272","volume":"23","author":"T Kozako","year":"2009","unstructured":"Kozako T, Yoshimitsu M, Fujiwara H, Masamoto I, Horai S, White Y, Akimoto M, Suzuki S, Matsushita K, Uozumi K, Tei C, Arima N (2009) PD-1\/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia\/lymphoma patients. Leukemia 23(2):375\u2013382. https:\/\/doi.org\/10.1038\/leu.2008.272","journal-title":"Leukemia"},{"issue":"2","key":"881_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/cen3.12395","volume":"8","author":"R Kubota","year":"2017","unstructured":"Kubota R (2017) Pathogenesis of human T-lymphotropic virus type 1-associated myelopathy\/tropical spastic paraparesis. Clin Exp Neuroimmunol 8(2):117\u2013128. https:\/\/doi.org\/10.1111\/cen3.12395","journal-title":"Clin Exp Neuroimmunol"},{"issue":"8","key":"881_CR64","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1182\/blood-2002-08-2477","volume":"101","author":"R Kubota","year":"2003","unstructured":"Kubota R, Furukawa Y, Izumo S, Usuku K, Osame M (2003) Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM\/TSP). Blood 101(8):3074\u20133081. https:\/\/doi.org\/10.1182\/blood-2002-08-2477","journal-title":"Blood"},{"issue":"1","key":"881_CR65","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4049\/jimmunol.161.1.482","volume":"161","author":"R Kubota","year":"1998","unstructured":"Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S (1998) Demonstration of human T lymphotropic virus type I (HTLV-I) Tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy\/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol 161(1):482\u2013488","journal-title":"J Immunol"},{"issue":"8","key":"881_CR66","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1349-7006.1993.tb02052.x","volume":"84","author":"S Kushida","year":"1993","unstructured":"Kushida S, Matsumura M, Tanaka H, Ami Y, Hori M, Kobayashi M, Uchida K, Yagami KI, Kameyama T, Yoshizawa T, Mizusawa H, Iwasaki Y, Miwa M (1993) HTLV-1-associated myelopathy\/tropical spastic paraparesis-like rats by intravenous injection of HTLV-1-producing rabbit or human T-cell line into adult WKA rats. Jpn J Cancer Res 84(8):831\u2013833. https:\/\/doi.org\/10.1111\/j.1349-7006.1993.tb02052.x","journal-title":"Jpn J Cancer Res"},{"issue":"39","key":"881_CR67","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1038\/sj.onc.1208974","volume":"24","author":"MD Lairmore","year":"2005","unstructured":"Lairmore MD, Silverman L, Ratner L (2005) Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene 24(39):6005\u20136015. https:\/\/doi.org\/10.1038\/sj.onc.1208974","journal-title":"Oncogene"},{"issue":"5","key":"881_CR68","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/v3050469","volume":"3","author":"B Macchi","year":"2011","unstructured":"Macchi B, Balestrieri E, Ascolani A, Hilburn S, Martin F, Mastino A, Taylor GP (2011) Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors. Viruses 3(5):469\u2013483. https:\/\/doi.org\/10.3390\/v3050469","journal-title":"Viruses"},{"issue":"9","key":"881_CR69","doi-asserted-by":"publisher","first-page":"e1001117","DOI":"10.1371\/journal.ppat.1001117","volume":"6","author":"A Macnamara","year":"2010","unstructured":"Macnamara A, Rowan A, Hilburn S, Kadolsky U, Fujiwara H, Suemori K et al (2010) HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog 6(9):e1001117. https:\/\/doi.org\/10.1371\/journal.ppat.1001117","journal-title":"PLoS Pathog"},{"issue":"6","key":"881_CR70","doi-asserted-by":"publisher","first-page":"E1269","DOI":"10.1073\/pnas.1715724115","volume":"115","author":"M Mahgoub","year":"2018","unstructured":"Mahgoub M, Yasunaga JI, Iwami S, Nakaoka S, Koizumi Y, Shimura K, Matsuoka M (2018) Sporadic on\/off switching of HTLV-1 Tax expression is crucial to maintain the whole population of virus-induced leukemic cells. Proc Natl Acad Sci U S A 115(6):E1269\u2013E1278. https:\/\/doi.org\/10.1073\/pnas.1715724115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"881_CR71","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1128\/JVI.69.9.5925-5927.1995","volume":"69","author":"R Mahieux","year":"1995","unstructured":"Mahieux R, de The G, Gessain A (1995) The Tax mutation at nucleotide 7959 of human T-cell leukemia virus type 1 (HTLV-1) is not associated with tropical spastic paraparesis\/HTLV-1-associated myelopathy but is linked to the cosmopolitan molecular genotype. J Virol 69(9):5925\u20135927","journal-title":"J Virol"},{"issue":"7","key":"881_CR72","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10875-013-9918-x","volume":"33","author":"SL Manuel","year":"2013","unstructured":"Manuel SL, Sehgal M, Connolly J, Makedonas G, Khan ZK, Gardner J, Betts MR, Jain P (2013) Lack of recall response to Tax in ATL and HAM\/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1. J Clin Immunol 33(7):1223\u20131239. https:\/\/doi.org\/10.1007\/s10875-013-9918-x","journal-title":"J Clin Immunol"},{"issue":"4","key":"881_CR73","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s004010050903","volume":"96","author":"E Matsuoka","year":"1998","unstructured":"Matsuoka E, Takenouchi N, Hashimoto K, Kashio N, Moritoyo T, Higuchi I, Isashiki Y, Sato E, Osame M, Izumo S (1998) Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy\/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization. Acta Neuropathol 96(4):340\u2013346","journal-title":"Acta Neuropathol"},{"issue":"12","key":"881_CR74","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/onc.2010.537","volume":"30","author":"M Matsuoka","year":"2011","unstructured":"Matsuoka M, Jeang KT (2011) Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 30(12):1379\u20131389. https:\/\/doi.org\/10.1038\/onc.2010.537","journal-title":"Oncogene"},{"issue":"1","key":"881_CR75","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NEN.0000000000000141","volume":"74","author":"E Matsuura","year":"2015","unstructured":"Matsuura E, Kubota R, Tanaka Y, Takashima H, Izumo S (2015) Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis. J Neuropathol Exp Neurol 74(1):2\u201314. https:\/\/doi.org\/10.1097\/NEN.0000000000000141","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"881_CR76","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/ana.410400114","volume":"40","author":"T Moritoyo","year":"1996","unstructured":"Moritoyo T, Reinhart TA, Moritoyo H, Sato E, Izumo S, Osame M et al (1996) Human T-lymphotropic virus type I-associated myelopathy and Tax gene expression in CD4+ T lymphocytes. Ann Neurol 40(1):84\u201390. https:\/\/doi.org\/10.1002\/ana.410400114","journal-title":"Ann Neurol"},{"issue":"6","key":"881_CR77","first-page":"586","volume":"4","author":"M Nagai","year":"1998","unstructured":"Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T et al (1998) Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neuro-Oncol 4(6):586\u2013593","journal-title":"J Neuro-Oncol"},{"issue":"6","key":"881_CR78","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/ana.10065","volume":"50","author":"M Nagai","year":"2001","unstructured":"Nagai M, Yamano Y, Brennan MB, Mora CA, Jacobson S (2001) Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM\/TSP. Ann Neurol 50(6):807\u2013812","journal-title":"Ann Neurol"},{"issue":"1","key":"881_CR79","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12977-018-0454-x","volume":"15","author":"T Naito","year":"2018","unstructured":"Naito T, Yasunaga JI, Mitobe Y, Shirai K, Sejima H, Ushirogawa H, Tanaka Y, Nakamura T, Hanada K, Fujii M, Matsuoka M, Saito M (2018) Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM\/TSP. Retrovirology 15(1):72. https:\/\/doi.org\/10.1186\/s12977-018-0454-x","journal-title":"Retrovirology"},{"issue":"5","key":"881_CR80","first-page":"345","volume":"2","author":"M Nakagawa","year":"1996","unstructured":"Nakagawa M, Nakahara K, Maruyama Y, Kawabata M, Higuchi I, Kubota H et al (1996) Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/ tropical spastic paraparesis. J Neuro-Oncol 2(5):345\u2013355","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"881_CR81","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ilar\/ilv045","volume":"57","author":"S Niewiesk","year":"2016","unstructured":"Niewiesk S (2016) Animals models of human T cell leukemia virus type I leukemogenesis. ILAR J 57(1):3\u201311. https:\/\/doi.org\/10.1093\/ilar\/ilv045","journal-title":"ILAR J"},{"issue":"1","key":"881_CR82","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12977-017-0350-9","volume":"14","author":"S Nozuma","year":"2017","unstructured":"Nozuma S, Matsuura E, Kodama D, Tashiro Y, Matsuzaki T, Kubota R, Izumo S, Takashima H (2017) Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy\/tropical spastic paraparesis. Retrovirology 14(1):26. https:\/\/doi.org\/10.1186\/s12977-017-0350-9","journal-title":"Retrovirology"},{"issue":"5","key":"881_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086144","volume":"9","author":"S Nozuma","year":"2014","unstructured":"Nozuma S, Matsuura E, Matsuzaki T, Watanabe O, Kubota R, Izumo S, Takashima H (2014) Familial clusters of HTLV-1-associated myelopathy\/tropical spastic paraparesis. PLoS One 9(5):e86144. https:\/\/doi.org\/10.1371\/journal.pone.0086144","journal-title":"PLoS One"},{"issue":"11","key":"881_CR84","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1086\/503874","volume":"193","author":"U Oh","year":"2006","unstructured":"Oh U, Grant C, Griffith C, Fugo K, Takenouchi N, Jacobson S (2006) Reduced Foxp3 protein expression is associated with inflammatory disease during human t lymphotropic virus type 1 infection. J Infect Dis 193(11):1557\u20131566. https:\/\/doi.org\/10.1086\/503874","journal-title":"J Infect Dis"},{"issue":"9","key":"881_CR85","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3727\/096504013X13657689383058","volume":"20","author":"T Ohsugi","year":"2013","unstructured":"Ohsugi T, Wakamiya M, Morikawa S, Matsuura K, Kumar JM, Kumasaka T, Yamaguchi K (2013) Invasion of histiocytic sarcoma into the spinal cord of HTLV-1 Tax transgenic mice with HTLV-1-associated myelopathy\/tropical spastic paraparesis-like disease. Oncol Res 20(9):403\u2013410. https:\/\/doi.org\/10.3727\/096504013X13657689383058","journal-title":"Oncol Res"},{"issue":"11","key":"881_CR86","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1001\/archneur.63.11.1560","volume":"63","author":"S Olindo","year":"2006","unstructured":"Olindo S, Cabre P, Lezin A, Merle H, Saint-Vil M, Signate A et al (2006) Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study. Arch Neurol 63(11):1560\u20131566. https:\/\/doi.org\/10.1001\/archneur.63.11.1560","journal-title":"Arch Neurol"},{"issue":"8488","key":"881_CR87","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","volume":"1","author":"M Osame","year":"1986","unstructured":"Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A et al (1986) HTLV-I associated myelopathy, a new clinical entity. Lancet 1(8488):1031\u20131032","journal-title":"Lancet"},{"key":"881_CR88","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4137\/VRT.S12140","volume":"4","author":"AR Panfil","year":"2013","unstructured":"Panfil AR, Al-Saleem JJ, Green PL (2013) Animal models utilized in HTLV-1 research. Virology (Auckl) 4:49\u201359. https:\/\/doi.org\/10.4137\/VRT.S12140","journal-title":"Virology (Auckl)"},{"issue":"3","key":"881_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093374","volume":"9","author":"R Pessoa","year":"2014","unstructured":"Pessoa R, Watanabe JT, Nukui Y, Pereira J, Casseb J, de Oliveira AC et al (2014) Molecular characterization of human T-cell lymphotropic virus type 1 full and partial genomes by Illumina massively parallel sequencing technology. PLoS One 9(3):e93374. https:\/\/doi.org\/10.1371\/journal.pone.0093374","journal-title":"PLoS One"},{"issue":"4","key":"881_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004040","volume":"10","author":"S Philip","year":"2014","unstructured":"Philip S, Zahoor MA, Zhi H, Ho YK, Giam CZ (2014) Regulation of human T-lymphotropic virus type I latency and reactivation by HBZ and Rex. PLoS Pathog 10(4):e1004040. https:\/\/doi.org\/10.1371\/journal.ppat.1004040","journal-title":"PLoS Pathog"},{"issue":"12","key":"881_CR91","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77(12):7415\u20137419","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"881_CR92","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1182\/blood-2010-11-316463","volume":"117","author":"F Rende","year":"2011","unstructured":"Rende F, Cavallari I, Corradin A, Silic-Benussi M, Toulza F, Toffolo GM, Tanaka Y, Jacobson S, Taylor GP, D'Agostino DM, Bangham CRM, Ciminale V (2011) Kinetics and intracellular compartmentalization of HTLV-1 gene expression: nuclear retention of HBZ mRNAs. Blood 117(18):4855\u20134859. https:\/\/doi.org\/10.1182\/blood-2010-11-316463","journal-title":"Blood"},{"issue":"1","key":"881_CR93","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12896-017-0379-9","volume":"17","author":"E Rosati","year":"2017","unstructured":"Rosati E, Dowds CM, Liaskou E, Henriksen EKK, Karlsen TH, Franke A (2017) Overview of methodologies for T-cell receptor repertoire analysis. BMC Biotechnol 17(1):61. https:\/\/doi.org\/10.1186\/s12896-017-0379-9","journal-title":"BMC Biotechnol"},{"key":"881_CR94","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12977-014-0116-6","volume":"11","author":"AG Rowan","year":"2014","unstructured":"Rowan AG, Suemori K, Fujiwara H, Yasukawa M, Tanaka Y, Taylor GP, Bangham CRM (2014) Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of Tax expression. Retrovirology 11:116. https:\/\/doi.org\/10.1186\/s12977-014-0116-6","journal-title":"Retrovirology"},{"key":"881_CR95","doi-asserted-by":"publisher","unstructured":"Rowan AG, Witkover A, Melamed A, Tanaka Y, Cook LBM, Fields P et al (2016) T cell receptor V beta staining identifies the malignant clone in adult T cell leukemia and reveals killing of leukemia cells by autologous CD8(+) T cells. Plos Pathogens 12(11). https:\/\/doi.org\/10.1371\/journal.ppat.1006030","DOI":"10.1371\/journal.ppat.1006030"},{"key":"881_CR96","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3389\/fmicb.2019.01101","volume":"10","author":"M Saito","year":"2019","unstructured":"Saito M (2019) Association between HTLV-1 genotypes and risk of HAM\/TSP. Front Microbiol 10:1101. https:\/\/doi.org\/10.3389\/fmicb.2019.01101","journal-title":"Front Microbiol"},{"key":"881_CR97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-6-19","volume":"6","author":"M Saito","year":"2009","unstructured":"Saito M, Matsuzaki T, Satou Y, Yasunaga J, Saito K, Arimura K, Matsuoka M, Ohara Y (2009) In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Retrovirology 6:19. https:\/\/doi.org\/10.1186\/1742-4690-6-19","journal-title":"Retrovirology"},{"issue":"2","key":"881_CR98","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1128\/JVI.75.2.1065-1071.2001","volume":"75","author":"M Saito","year":"2001","unstructured":"Saito M, Taylor GP, Saito A, Furukawa Y, Usuku K, Weber JN, Osame M, Bangham CRM (2001) In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes. J Virol 75(2):1065\u20131071. https:\/\/doi.org\/10.1128\/JVI.75.2.1065-1071.2001","journal-title":"J Virol"},{"issue":"6","key":"881_CR99","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMoa1704827","volume":"378","author":"T Sato","year":"2018","unstructured":"Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y (2018) Mogamulizumab (anti-CCR4) in HTLV-1-associated myelopathy. N Engl J Med 378(6):529\u2013538. https:\/\/doi.org\/10.1056\/NEJMoa1704827","journal-title":"N Engl J Med"},{"issue":"11","key":"881_CR100","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1073\/pnas.1423199113","volume":"113","author":"Y Satou","year":"2016","unstructured":"Satou Y, Miyazato P, Ishihara K, Yaguchi H, Melamed A, Miura M, Fukuda A, Nosaka K, Watanabe T, Rowan AG, Nakao M, Bangham CRM (2016) The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome. Proc Natl Acad Sci U S A 113(11):3054\u20133059. https:\/\/doi.org\/10.1073\/pnas.1423199113","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"881_CR101","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1073\/pnas.0507631103","volume":"103","author":"Y Satou","year":"2006","unstructured":"Satou Y, Yasunaga J, Yoshida M, Matsuoka M (2006) HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A 103(3):720\u2013725. https:\/\/doi.org\/10.1073\/pnas.0507631103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"881_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001274","volume":"7","author":"Y Satou","year":"2011","unstructured":"Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, Shimizu K, Ohshima K, Green PL, Ohkura N, Yamaguchi T, Ono M, Sakaguchi S, Matsuoka M (2011) HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog 7(2):e1001274. https:\/\/doi.org\/10.1371\/journal.ppat.1001274","journal-title":"PLoS Pathog"},{"issue":"5","key":"881_CR103","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1128\/AAC.01413-10","volume":"55","author":"ME Seegulam","year":"2011","unstructured":"Seegulam ME, Ratner L (2011) Integrase inhibitors effective against human T-cell leukemia virus type 1. Antimicrob Agents Chemother 55(5):2011\u20132017. https:\/\/doi.org\/10.1128\/AAC.01413-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 8","key":"881_CR104","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1099\/vir.0.010199-0","volume":"90","author":"K Suemori","year":"2009","unstructured":"Suemori K, Fujiwara H, Ochi T, Ogawa T, Matsuoka M, Matsumoto T, Mesnard JM, Yasukawa M (2009) HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. J Gen Virol 90(Pt 8):1806\u20131811. https:\/\/doi.org\/10.1099\/vir.0.010199-0","journal-title":"J Gen Virol"},{"issue":"17","key":"881_CR105","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1158\/0008-5472.CAN-16-0361","volume":"76","author":"K Sugata","year":"2016","unstructured":"Sugata K, Yasunaga J, Kinosada H, Mitobe Y, Furuta R, Mahgoub M, Onishi C, Nakashima K, Ohshima K, Matsuoka M (2016) HTLV-1 viral factor HBZ induces CCR4 to promote T-cell migration and proliferation. Cancer Res 76(17):5068\u20135079. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0361","journal-title":"Cancer Res"},{"key":"881_CR106","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fmicb.2018.00461","volume":"9","author":"A Tanaka","year":"2018","unstructured":"Tanaka A, Matsuoka M (2018) HTLV-1 alters T cells for viral persistence and transmission. Front Microbiol 9:461. https:\/\/doi.org\/10.3389\/fmicb.2018.00461","journal-title":"Front Microbiol"},{"key":"881_CR107","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1742-4690-3-63","volume":"3","author":"GP Taylor","year":"2006","unstructured":"Taylor GP, Goon P, Furukawa Y, Green H, Barfield A, Mosley A, Nose H, Babiker A, Rudge P, Usuku K, Osame M, Bangham CRM, Weber JN (2006) Zidovudine plus lamivudine in human T-lymphotropic virus type-I-associated myelopathy: a randomised trial. Retrovirology 3:63. https:\/\/doi.org\/10.1186\/1742-4690-3-63","journal-title":"Retrovirology"},{"issue":"3","key":"881_CR108","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50(3):481\u2013492","journal-title":"Blood"},{"issue":"4","key":"881_CR109","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/00005072-199307000-00010","volume":"52","author":"F Umehara","year":"1993","unstructured":"Umehara F, Izumo S, Nakagawa M, Ronquillo AT, Takahashi K, Matsumuro K, Sato E, Osame M (1993) Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 52(4):424\u2013430","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"881_CR110","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/00005072-199411000-00009","volume":"53","author":"F Umehara","year":"1994","unstructured":"Umehara F, Nakamura A, Izumo S, Kubota R, Ijichi S, Kashio N et al (1994) Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol 53(6):617\u2013624. https:\/\/doi.org\/10.1097\/00005072-199411000-00009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"881_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003630","volume":"9","author":"N Yamamoto-Taguchi","year":"2013","unstructured":"Yamamoto-Taguchi N, Satou Y, Miyazato P, Ohshima K, Nakagawa M, Katagiri K, Kinashi T, Matsuoka M (2013) HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression. PLoS Pathog 9(9):e1003630. https:\/\/doi.org\/10.1371\/journal.ppat.1003630","journal-title":"PLoS Pathog"},{"issue":"8","key":"881_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006517","volume":"4","author":"Y Yamano","year":"2009","unstructured":"Yamano Y, Araya N, Sato T, Utsunomiya A, Azakami K, Hasegawa D, Izumi T, Fujita H, Aratani S, Yagishita N, Fujii R, Nishioka K, Jacobson S, Nakajima T (2009) Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder. PLoS One 4(8):e6517. https:\/\/doi.org\/10.1371\/journal.pone.0006517","journal-title":"PLoS One"},{"issue":"10","key":"881_CR113","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20032042","volume":"199","author":"Y Yamano","year":"2004","unstructured":"Yamano Y, Cohen CJ, Takenouchi N, Yao K, Tomaru U, Li HC, Reiter Y, Jacobson S (2004) Increased expression of human T lymphocyte virus type I (HTLV-I) Tax11-19 peptide-human histocompatibility leukocyte antigen a*201 complexes on CD4+ CD25+ T cells detected by peptide-specific, major histocompatibility complex-restricted antibodies in patients with HTLV-I-associated neurologic disease. J Exp Med 199(10):1367\u20131377. https:\/\/doi.org\/10.1084\/jem.20032042","journal-title":"J Exp Med"},{"key":"881_CR114","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jneuroim.2016.08.012","volume":"304","author":"Y Yamano","year":"2017","unstructured":"Yamano Y, Coler-Reilly A (2017) HTLV-1 induces a Th1-like state in CD4(+)CCR4(+) T cells that produces an inflammatory positive feedback loop via astrocytes in HAM\/TSP. J Neuroimmunol 304:51\u201355. https:\/\/doi.org\/10.1016\/j.jneuroim.2016.08.012","journal-title":"J Neuroimmunol"},{"issue":"1","key":"881_CR115","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/blood.V99.1.88","volume":"99","author":"Y Yamano","year":"2002","unstructured":"Yamano Y, Nagai M, Brennan M, Mora CA, Soldan SS, Tomaru U, Takenouchi N, Izumo S, Osame M, Jacobson S (2002) Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM\/TSP). Blood 99(1):88\u201394","journal-title":"Blood"},{"issue":"5","key":"881_CR116","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1172\/JCI23913","volume":"115","author":"Y Yamano","year":"2005","unstructured":"Yamano Y, Takenouchi N, Li HC, Tomaru U, Yao K, Grant CW, Maric DA, Jacobson S (2005) Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J Clin Invest 115(5):1361\u20131368. https:\/\/doi.org\/10.1172\/JCI23913","journal-title":"J Clin Invest"},{"issue":"2","key":"881_CR117","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/infdis\/jiu438","volume":"211","author":"J Yamauchi","year":"2015","unstructured":"Yamauchi J, Coler-Reilly A, Sato T, Araya N, Yagishita N, Ando H, Kunitomo Y, Takahashi K, Tanaka Y, Shibagaki Y, Nishioka K, Nakajima T, Hasegawa Y, Utsunomiya A, Kimura K, Yamano Y (2015) Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy. J Infect Dis 211(2):238\u2013248. https:\/\/doi.org\/10.1093\/infdis\/jiu438","journal-title":"J Infect Dis"},{"issue":"4","key":"881_CR118","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s13365-015-0407-2","volume":"22","author":"K Yasuma","year":"2016","unstructured":"Yasuma K, Matsuzaki T, Yamano Y, Takashima H, Matsuoka M, Saito M (2016a) HTLV-1 subgroups associated with the risk of HAM\/TSP are related to viral and host gene expression in peripheral blood mononuclear cells, independent of the transactivation functions of the viral factors. J Neuro-Oncol 22(4):416\u2013430. https:\/\/doi.org\/10.1007\/s13365-015-0407-2","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"881_CR119","doi-asserted-by":"publisher","first-page":"e1005372","DOI":"10.1371\/journal.ppat.1005372","volume":"12","author":"K Yasuma","year":"2016","unstructured":"Yasuma K, Yasunaga J, Takemoto K, Sugata K, Mitobe Y, Takenouchi N, Nakagawa M, Suzuki Y, Matsuoka M (2016b) HTLV-1 bZIP factor impairs anti-viral immunity by inducing co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT). PLoS Pathog 12(1):e1005372. https:\/\/doi.org\/10.1371\/journal.ppat.1005372","journal-title":"PLoS Pathog"},{"issue":"9","key":"881_CR120","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/jnnp.56.9.1004","volume":"56","author":"A Yoshioka","year":"1993","unstructured":"Yoshioka A, Hirose G, Ueda Y, Nishimura Y, Sakai K (1993) Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM). J Neurol Neurosurg Psychiatry 56(9):1004\u20131007","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"881_CR121","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1182\/blood-2010-12-326199","volume":"118","author":"T Zhao","year":"2011","unstructured":"Zhao T, Satou Y, Sugata K, Miyazato P, Green PL, Imamura T, Matsuoka M (2011) HTLV-1 bZIP factor enhances TGF-beta signaling through p300 coactivator. Blood 118(7):1865\u20131876. https:\/\/doi.org\/10.1182\/blood-2010-12-326199","journal-title":"Blood"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-020-00881-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-020-00881-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-020-00881-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T18:37:29Z","timestamp":1696444649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-020-00881-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,23]]},"references-count":121,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["881"],"URL":"https:\/\/doi.org\/10.1007\/s13365-020-00881-w","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,23]]},"assertion":[{"value":"29 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}